Company:  GT BIOPHARMA, INC. (GTBP)
Form Type:  S-1
Filing Date:  9/13/2019 
CIK:  0000109657 
Address:  310 N. WESTLAKE BLVD.
SUITE 206
 
City, State, Zip:  WESTLAKE VILLAGE, California 91362 
Telephone:  (800) 304-9888 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.19  
Change: 
-0.003 (-1.68%)  
Trade Time: 
Aug 06  
Market Cap: 
$14.55M
Trade GTBP now with 

© 2020  
Description of Business
We are a clinical stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products based off our proprietary Tri-specific Killer Engager (TriKE(TM)), Tetra-specific Killer Engager (TetraKE(TM)) and bi-specific ligand-directed single-chain fusion protein technology platforms. Our TriKE and TetraKE platforms generate proprietary therapeutics designed to harness and enhance the cancer killing abilities of a patient's own natural killer cells, or NK cells. Once bound to an NK cell, our moieties are designed to enhance the NK cell, and precisely direct it to one or more specifically-targeted proteins expressed on a specific type of cancer cell or virus infected cell, ultimately resulting in the targeted cell's death.
Register and access this filing in:     
  FORM S-1
    CALCULATION OF REGISTRATION FEE
    TABLE OF CONTENTS
    ABOUT THIS PROSPECTUS
    SUBJECT TO COMPLETION, DATED SEPTEMBER 3, 2019
    Summary Risk Factors
    THE OFFERING
    Summary Financial Information
      BALANCE SHEET
      INCOME STATEMENT
      BALANCE SHEET
    RISK FACTORS
    USE OF PROCEEDS
    MARKET FOR OUR COMMON STOCK AND RELATED STOCKHOLDER MATTERS
    MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ...
    CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS
      Liquidity and Capital Resources
    DESCRIPTION OF BUSINESS
      Employees
      Legal Proceedings
    MANAGEMENT
      NAME AND TITLE
    EXECUTIVE COMPENSATION
      COMPENSATION TABLE
    Director Compensation
    VOTING SECURITIES AND PRINCIPAL HOLDERS
      BENEFICIAL OWNERS
    SELLING STOCKHOLDERS
    PLAN OF DISTRIBUTION
    DESCRIPTION OF CAPITAL STOCK
    Transfer Agent and Registrar
    LEGAL MATTERS
    EXPERTS
    WHERE YOU CAN FIND MORE INFORMATION
      REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
      OPTIONS
      BALANCE SHEET
      INCOME STATEMENT
      CASH FLOW
    PART II
      ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION
      ITEM 15. RECENT SALES OF UNREGISTERED SECURITIES
      ITEM 16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
      ITEM 24. INDEMNIFICATION OF DIRECTORS AND OFFICERS
      ITEM 28. UNDERTAKINGS
    SIGNATURES
    POWER OF ATTORNEY
  EXHIBIT 5.1
  EXHIBIT 23.1